NCT06329921View on ClinicalTrials.gov

Inpatient Monitoring of Unfractionated Heparin

NAEnrolling by invitationINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

June 26, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions
Blood ClotThrombosis
Interventions
OTHER

PTT protocol

Patients will be monitored using the nurse-managed PTT protocol.

OTHER

anti-Xa protocol

Patients will be monitored using the pharmacy-managed anti-Xa protocol.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER